Curious to know which obesity stories grabbed the attention of readers this year? Medscape Medical News develops a list of ...
While childhood obesity has become more common in recent years, this is a condition that is about more than just weight.
From changing the definition to the rise of GLP-1 medications, and especially Prime Minister Narendra Modi’s clarion call against obesity ...
Industry analysis examines published SURMOUNT clinical trial data, evolving FDA compounding guidance, and telehealth access ...
Do not focus only on weight, but waist size matters!’ 'Beer belly' or abdominal obesity has been largely identified as a ...
A new analysis from the landmark FOURIER trial published in the Journal of the American College of Cardiology suggests that ...
A meta-analysis of 10,362 patients with inflammatory bowel disease has found that GLP-1 receptor agonists are safe and ...
The Best Weight Loss Supplements for Women This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: The best ...
Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access ...
6d
FDA approves Novo Nordisk's Wegovy(R) pill, the first and only oral GLP-1 for weight loss in adults
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy (R) pill, the first oral GLP-1 medicine for obesity in the US. (3) Wegovy (R) pill is used ...
The drugs' high prices, along with spotty insurance coverage, have left them out of reach for many Americans. Read more at ...
GLP-1 medicines have been utilised for the treatment of diabetes; however, they are now emerging as important topics for the treatment of obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback